1478-6354

Arthritis Research & Therapy

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 3653 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact3653 DOIs
2

Add abstracts to 1388 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact1388 DOIs
3

Add license metadata to 913 records

License metadata tells indexers and readers how each article may be reused.

Low impact913 DOIs

DOIs for this ISSN

Showing the top 5 of 3653 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Mesenchymal precursor cells in the blood of normal individua… (10.1186/ar130)
Abstract ORCID License
204.50 532
2 Incidence of malignancy in adult patients with rheumatoid ar… (10.1186/s13075-015-0728-9)
Abstract ORCID License
200.96 477
3 Efficacy and safety of adult human bone marrow-derived, cult… (10.1186/s13075-016-1195-7)
Abstract ORCID License
184.90 291
4 Prevalence of peripheral and extra-articular disease in anky… (10.1186/s13075-016-1093-z)
Abstract ORCID License
180.74 256
5 New insights on the MMP-13 regulatory network in the pathoge… (10.1186/s13075-017-1454-2)
Abstract ORCID License
179.58 247
6 Fatigue in chronic inflammation - a link to pain pathways (10.1186/s13075-015-0784-1)
Abstract ORCID License
167.28 169
7 Enhanced IgG4 production by follicular helper 2 T cells and… (10.1186/s13075-016-1064-4)
Abstract ORCID License
165.71 161
8 MicroRNAs in fibrosis: opportunities and challenges (10.1186/s13075-016-0929-x)
Abstract ORCID License
164.48 155
9 A phase III randomized study to evaluate the efficacy and sa… (10.1186/s13075-016-0981-6)
Abstract ORCID License
162.99 148
10 Tofacitinib, an oral Janus kinase inhibitor, as monotherapy… (10.1186/s13075-016-0932-2)
Abstract ORCID License
159.78 134
11 CD163+ M2c-like macrophages predominate in renal biopsies fr… (10.1186/s13075-016-0989-y)
Abstract ORCID License
158.55 129
12 Usefulness of lung ultrasound B-lines in connective tissue d… (10.1186/s13075-017-1409-7)
Abstract ORCID License
158.55 129
13 Comparable long-term efficacy, as assessed by patient-report… (10.1186/s13075-016-0930-4)
Abstract ORCID License
157.27 124
14 Whole-genome transcription and DNA methylation analysis of p… (10.1186/s13075-016-1050-x)
Abstract ORCID License
157.27 124
15 Circulating plasmablasts/plasma cells: a potential biomarker… (10.1186/s13075-017-1231-2)
Abstract ORCID License
155.39 117
16 TLR2 stimulation impairs anti-inflammatory activity of M2-li… (10.1186/s13075-017-1447-1)
Abstract ORCID License
154.55 114
17 Glutaminase 1 plays a key role in the cell growth of fibrobl… (10.1186/s13075-017-1283-3)
Abstract ORCID License
154.27 113
18 Synovial stromal cells from rheumatoid arthritis patients at… (10.1186/ar149)
Abstract ORCID License
152.51 107
19 From osteoarthritic synovium to synovial-derived cells chara… (10.1186/s13075-016-0983-4)
Abstract ORCID License
152.51 107
20 Lesinurad, a novel, oral compound for gout, acts to decrease… (10.1186/s13075-016-1107-x)
Abstract ORCID License
152.51 107
21 Soluble uric acid increases PDZK1 and ABCG2 expression in hu… (10.1186/s13075-018-1512-4)
Abstract ORCID License
152.20 106
22 B cell repopulation kinetics after rituximab treatment in AN… (10.1186/s13075-017-1306-0)
Abstract ORCID License
151.90 105
23 Chinese Registry of rheumatoid arthritis (CREDIT): II. preva… (10.1186/s13075-017-1457-z)
Abstract ORCID License
151.90 105
24 Rheumatoid synovial fibroblasts differentiate into distinct… (10.1186/s13075-016-1156-1)
Abstract ORCID License
149.67 98
25 Persistent stromal fibroblast activation is present in chron… (10.1186/s13075-016-1218-4)
Abstract ORCID License
149.67 98
26 Comparison of 2002 AECG and 2016 ACR/EULAR classification cr… (10.1186/s13075-017-1475-x)
Abstract ORCID License
149.01 96
27 Poor prognostic factors guiding treatment decisions in rheum… (10.1186/s13075-017-1266-4)
Abstract ORCID License
148.67 95
28 Colony-stimulating factor (CSF) 1 receptor blockade reduces… (10.1186/s13075-016-0973-6)
Abstract ORCID License
147.98 93
29 Synovitis in osteoarthritis: current understanding with ther… (10.1186/s13075-017-1229-9)
Abstract License
147.66 897
30 Association between biomarkers of tissue inflammation and pr… (10.1186/s13075-016-0976-3)
Abstract ORCID License
146.93 90
31 A longitudinal study of fecal calprotectin and the developme… (10.1186/s13075-017-1223-2)
Abstract ORCID License
146.93 90
32 CD14brightCD16+ intermediate monocytes are induced by interl… (10.1186/s13075-016-1216-6)
Abstract ORCID License
146.20 88
33 E2 regulates MMP-13 via targeting miR-140 in IL-1β-induced e… (10.1186/s13075-016-0997-y)
Abstract ORCID License
144.71 84
34 Monosodium urate crystals induce oxidative stress in human s… (10.1186/s13075-016-1012-3)
Abstract ORCID License
144.71 84
35 Systemic sclerosis associated interstitial lung disease - in… (10.1186/s13075-018-1517-z)
Abstract ORCID License
144.71 84
36 Concentration of antibodies against Porphyromonas gingivalis… (10.1186/s13075-016-1100-4)
Abstract ORCID License
143.93 82
37 Evaluation of the impact of fibromyalgia in disease activity… (10.1186/s13075-016-0943-z)
Abstract ORCID License
143.54 81
38 High-mobility group box 1 potentiates antineutrophil cytopla… (10.1186/s13075-015-0903-z)
Abstract ORCID License
143.14 80
39 Changes in plasma CXCL4 levels are associated with improveme… (10.1186/s13075-016-1203-y)
Abstract ORCID License
143.14 80
40 Articular cartilage and changes in Arthritis: Cell biology o… (10.1186/ar148)
Abstract ORCID
143.08 726
41 Association of medial meniscal extrusion with medial tibial… (10.1186/s13075-017-1411-0)
Abstract ORCID License
142.73 79
42 Transient receptor potential ankyrin 1 (TRPA1) receptor is i… (10.1186/s13075-015-0904-y)
Abstract ORCID License
141.91 77
43 Comparison of treatment response, remission rate and drug ad… (10.1186/s13075-016-1170-3)
Abstract ORCID License
141.49 76
44 Circulating DNA in rheumatoid arthritis: pathological change… (10.1186/s13075-017-1295-z)
Abstract ORCID License
141.49 76
45 Impact of obesity on the response to tumor necrosis factor i… (10.1186/s13075-017-1372-3)
Abstract ORCID License
141.49 76
46 Clinical features of IgG4-related periaortitis/periarteritis… (10.1186/s13075-017-1432-8)
Abstract ORCID License
141.49 76
47 Transcriptional regulation of collagenase (MMP-1, MMP-13) ge… (10.1186/ar401)
Abstract ORCID
141.30 669
48 Overexpression of TLR2 and TLR9 on monocyte subsets of activ… (10.1186/s13075-015-0901-1)
Abstract ORCID License
140.19 73
49 Tapering and discontinuation of TNF-α blockers without disea… (10.1186/s13075-016-0927-z)
Abstract ORCID License
140.19 73
50 Co-morbidity in patients with early rheumatoid arthritis - i… (10.1186/s13075-016-0928-y)
Abstract ORCID License
140.19 73